FDA Issues New Regulations on Patient Access to Experimental Drugs

Patients with serious or immediately life threatening diseases, like cancer, who have exhausted all other commercially available treatments, often want to try a promising drug that is still under development. It is understandable that people with a disease with no good treatment options and their treating physicians are very interested in trying a new drug under development, especially if the early results of a clinical trial suggest that the drug shows promise.

Click the link below to read the full alert.